Episodio – Bevacizumab, VEGF y dehiscencia de heridas | USMLE Step 1

from USMLE DREAMERS · host USMLE DREAMERS

En este episodio analizamos un caso de dehiscencia de herida secundaria al uso de bevacizumab, un anticuerpo monoclonal anti-VEGF. Revisamos las fases de cicatrización, el papel crítico de la angiogénesis mediada por VEGF y por qué su inhibición produce fracaso tardío del cierre de heridas.#USMLEDreamers #USMLEStep1 #Pathology #Pharmacology #WoundHealing #Bevacizumab #VEGF #Angiogenesis #IMG #Step1Español

What this episode covers

NOW PLAYING

0:00 6:48

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of USMLE DREAMERS?

This episode is 6 minutes long.

When was this USMLE DREAMERS episode published?

This episode was published on January 23, 2026.

What is this episode about?

Can I download this USMLE DREAMERS episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.

URL copied to clipboard!